JP2016121177A5 - - Google Patents

Download PDF

Info

Publication number
JP2016121177A5
JP2016121177A5 JP2016041508A JP2016041508A JP2016121177A5 JP 2016121177 A5 JP2016121177 A5 JP 2016121177A5 JP 2016041508 A JP2016041508 A JP 2016041508A JP 2016041508 A JP2016041508 A JP 2016041508A JP 2016121177 A5 JP2016121177 A5 JP 2016121177A5
Authority
JP
Japan
Prior art keywords
compound
formula
mixture
alkyl
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016041508A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016121177A (ja
JP6087005B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016121177A publication Critical patent/JP2016121177A/ja
Publication of JP2016121177A5 publication Critical patent/JP2016121177A5/ja
Application granted granted Critical
Publication of JP6087005B2 publication Critical patent/JP6087005B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016041508A 2011-01-21 2016-03-03 縮合アミノジヒドロチアジン誘導体の合成に有用な方法および化合物 Expired - Fee Related JP6087005B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161434849P 2011-01-21 2011-01-21
US61/434,849 2011-01-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013550622A Division JP5993875B2 (ja) 2011-01-21 2012-01-20 縮合アミノジヒドロチアジン誘導体の合成に有用な方法および化合物

Publications (3)

Publication Number Publication Date
JP2016121177A JP2016121177A (ja) 2016-07-07
JP2016121177A5 true JP2016121177A5 (OSRAM) 2016-09-01
JP6087005B2 JP6087005B2 (ja) 2017-03-01

Family

ID=45563570

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013550622A Expired - Fee Related JP5993875B2 (ja) 2011-01-21 2012-01-20 縮合アミノジヒドロチアジン誘導体の合成に有用な方法および化合物
JP2016041508A Expired - Fee Related JP6087005B2 (ja) 2011-01-21 2016-03-03 縮合アミノジヒドロチアジン誘導体の合成に有用な方法および化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013550622A Expired - Fee Related JP5993875B2 (ja) 2011-01-21 2012-01-20 縮合アミノジヒドロチアジン誘導体の合成に有用な方法および化合物

Country Status (12)

Country Link
US (3) US8426584B2 (OSRAM)
EP (1) EP2665716B1 (OSRAM)
JP (2) JP5993875B2 (OSRAM)
CN (2) CN103502231A (OSRAM)
BR (1) BR112013016241A2 (OSRAM)
CA (1) CA2814014A1 (OSRAM)
ES (1) ES2624288T3 (OSRAM)
IL (1) IL226405A0 (OSRAM)
MX (1) MX2013005115A (OSRAM)
RU (1) RU2013138226A (OSRAM)
SG (2) SG191710A1 (OSRAM)
WO (1) WO2012100179A1 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100317850A1 (en) 2008-01-18 2010-12-16 Yuichi Suzuki Condensed aminodihydrothiazine derivative
GB0912778D0 (en) 2009-07-22 2009-08-26 Eisai London Res Lab Ltd Fused aminodihydro-oxazine derivatives
GB0912777D0 (en) 2009-07-22 2009-08-26 Eisai London Res Lab Ltd Fused aminodihydropyrimidone derivatives
GB201100181D0 (en) 2011-01-06 2011-02-23 Eisai Ltd Fused aminodihydrothiazine derivatives
GB201101140D0 (en) * 2011-01-21 2011-03-09 Eisai Ltd Fused aminodihydrothiazine derivatives
GB201101139D0 (en) * 2011-01-21 2011-03-09 Eisai Ltd Fused aminodihydrothiazine derivatives
UY34278A (es) 2011-08-25 2013-04-05 Novartis Ag Derivados novedosos de oxazina y su uso en el tratamiento de enfermedades
GB201212816D0 (en) * 2012-07-19 2012-09-05 Eisai Ltd Novel compounds
TWI639607B (zh) 2013-06-18 2018-11-01 美國禮來大藥廠 Bace抑制劑
CA2963761C (en) * 2014-10-10 2023-10-17 Eisai R&D Management Co., Ltd. Pharmaceutical composition of fused aminodihydrothiazine derivative
IL316169A (en) 2016-10-27 2024-12-01 Eisai R&D Man Co Ltd Composition comprising an anti-abeta protofibril antibody and a beta-secretase bace1 inhibitor for the treatment of alzheimer's disease
CA3107370A1 (en) 2018-07-24 2020-01-30 Eisai R&D Management Co., Ltd. Methods of treatment and prevention of alzheimer's disease

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3235551A (en) 1966-02-15 Novel derivatives of
US3227713A (en) 1966-01-04 Azine derivatives
JPH0967355A (ja) 1995-08-31 1997-03-11 Tokyo Tanabe Co Ltd チアジン誘導体、チアゾール誘導体及びそれらの製造方法
US20040110743A1 (en) 2000-05-19 2004-06-10 Masaomi Miyamato -Secretase inhibitors
US6562783B2 (en) 2001-05-30 2003-05-13 Neurologic, Inc. Phosphinylmethyl and phosphorylmethyl succinic and glutauric acid analogs as β-secretase inhibitors
AU2003254844A1 (en) 2002-08-09 2004-02-25 Takeda Chemical Industries, Ltd. Substituted amino compounds and use thereof
WO2004037212A2 (en) 2002-10-24 2004-05-06 Sepracor, Inc. Compositions comprising zopiclone derivatives and methods of making and using the same
JP2004149429A (ja) 2002-10-29 2004-05-27 Takeda Chem Ind Ltd インドール化合物およびその用途
WO2004043916A1 (en) 2002-11-12 2004-05-27 Merck & Co., Inc. Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
NZ547462A (en) 2003-12-15 2010-06-25 Schering Corp Heterocyclic aspartyl protease inhibitors
US20070203147A1 (en) 2004-03-30 2007-08-30 Coburn Craig A 2-Aminothiazole Compounds Useful As Aspartyl Protease Inhibitors
PE20060664A1 (es) 2004-09-15 2006-08-04 Novartis Ag Amidas biciclicas como inhibidores de cinasa
EP1802587A4 (en) 2004-10-15 2010-02-17 Astrazeneca Ab SUBSTITUTED AMINO BINDINGS AND THEIR APPLICATIONS
WO2006041405A1 (en) 2004-10-15 2006-04-20 Astrazeneca Ab Substituted amino-pyrimidones and uses thereof
AU2006206654A1 (en) 2005-01-19 2006-07-27 Merck & Co., Inc. Tertiary carbinamines having substituted heterocycles, which are active as inhibitors of beta-secretase, for the treatment of Alzheimer's disease
CA2609582A1 (en) 2005-06-14 2006-12-28 Schering Corporation Aspartyl protease inhibitors
AU2006270084B2 (en) 2005-07-18 2011-08-25 Merck Sharp & Dohme Corp. Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease
US8173642B2 (en) 2005-10-25 2012-05-08 Shionogi & Co., Ltd. Aminodihydrothiazine derivatives
CN101460480A (zh) 2006-04-05 2009-06-17 阿斯利康(瑞典)有限公司 2-氨基嘧啶-4-酮类化合物及其用于治疗或预防Aβ相关病理的用途
US8049006B2 (en) 2006-05-31 2011-11-01 Daiichi Sankyo Company, Limited 7-membered ring compound and method of production and pharmaceutical application thereof
CA2672293A1 (en) 2006-12-12 2008-06-19 Schering Corporation Aspartyl protease inhibitors
EP2151435A4 (en) * 2007-04-24 2011-09-14 Shionogi & Co PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
MX2009011498A (es) 2007-04-24 2009-11-10 Shionogi & Co Derivados de aminodihidrotiazina sustituida con un grupo ciclico.
PL2151436T3 (pl) 2007-05-29 2013-09-30 Santen Pharmaceutical Co Ltd Nowe pochodne 1,2,3,4-tetrahydrochinoksaliny, które jako podstawnik zawierają grupę fenylową z wprowadzoną strukturą estru kwasu sulfonowego lub amidu kwasu sulfonowego i które mają aktywność wiążącą wobec receptora glukokortykoidowego
PE20091236A1 (es) 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
US20100317850A1 (en) 2008-01-18 2010-12-16 Yuichi Suzuki Condensed aminodihydrothiazine derivative
TWI431004B (zh) 2008-05-02 2014-03-21 Lilly Co Eli Bace抑制劑
KR20110048491A (ko) 2008-07-28 2011-05-11 에자이 알앤드디 매니지먼트 가부시키가이샤 스피로아미노디하이드로티아진 유도체들
WO2010013302A1 (ja) 2008-07-28 2010-02-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 スピロアミノジヒドロチアジン誘導体
ES2539859T3 (es) 2008-09-30 2015-07-06 Eisai R&D Management Co., Ltd. Nuevo derivado de aminodihidrotiazina condensado
AR077277A1 (es) * 2009-07-09 2011-08-17 Lilly Co Eli Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer
GB0912777D0 (en) 2009-07-22 2009-08-26 Eisai London Res Lab Ltd Fused aminodihydropyrimidone derivatives
GB0912778D0 (en) 2009-07-22 2009-08-26 Eisai London Res Lab Ltd Fused aminodihydro-oxazine derivatives
US20130085131A1 (en) 2010-07-01 2013-04-04 Amgen Inc. Heterocyclic compounds and their uses
GB201101140D0 (en) 2011-01-21 2011-03-09 Eisai Ltd Fused aminodihydrothiazine derivatives

Similar Documents

Publication Publication Date Title
JP2016121177A5 (OSRAM)
JP2014503001A5 (OSRAM)
JP2018193405A5 (OSRAM)
JP6050358B2 (ja) ベンゾオキサジノンをアミンと反応させることによるテトラゾール置換アントラニル酸ジアミド誘導体の製造方法
JP2005530694A5 (OSRAM)
JP2012504153A5 (OSRAM)
RU2013138226A (ru) Способы и соединения, пригодные для получения конденсированных аминодигидротиазиновых производных
JP2006137778A5 (OSRAM)
JP2013533267A5 (OSRAM)
JP2017505801A5 (OSRAM)
JP2013508368A5 (OSRAM)
JP7232618B2 (ja) アコチアミドの改善された製造方法
JP6239003B2 (ja) 4−アミノ−5−フルオロ−3−クロロ−6−(置換)ピコリネートの調製方法
JP2007517012A5 (OSRAM)
JP2008247753A5 (OSRAM)
EP3608324A1 (en) Method for preparing 2-arylmalonamide and applications of method
JP2014009330A5 (OSRAM)
CN108689874B (zh) 一种制备2-芳基丙二酰胺的方法及其应用
TW201326116A (zh) 2,6-二乙基-4-甲基苯醋酸之製造方法
JP2015524846A5 (OSRAM)
CN105037331B (zh) 瑞舒伐他汀中间体的制备方法
JP2014214127A5 (OSRAM)
WO2003014067A1 (fr) Methode de production d'un compose beta-oxonitrile ou d'un sel de metal alcalin dudit compose
WO2015151190A1 (ja) イルソグラジンマレイン酸塩の製造方法
CN107162923B (zh) 一种邻氨基苯乙酮的制备方法